Sang-Won Yoo

Dr. Sang-Won Yoo

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Radiology
Verified
Journal Article
Closed access
NSNa-Young Shin
Na-Young Shin
MBMirim Bang
Mirim Bang
SYSang-Won Yoo
Sang-Won Yoo
JKJoong-Seok Kim
Joong-Seok Kim
EYEunkyeong Yun
Eunkyeong Yun
SLSeung-Koo Lee
Seung-Koo Lee
Cortical thickness from MRI can improve prediction of conversion from mild cognitive impairment to dementia in Parkinson disease at an individual level when integrated with clinical variables. Background Group comparison results associating cortical thinning and Parkinson disease (PD) dementia (PDD) are limited in their application to clinical settings. Purpose To investigate whether cor...

28 February 2019 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
SYSang-Won Yoo
Sang-Won Yoo
JKJoong-Seok Kim
Joong-Seok Kim
YOYoon-Sang Oh
Yoon-Sang Oh
DRDong-Woo Ryu
Dong-Woo Ryu
KLKwang-Soo Lee
Kwang-Soo Lee

1 April 2019 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
DRDong-Woo Ryu
Dong-Woo Ryu
JKJoong-Seok Kim
Joong-Seok Kim
JLJee-Eun Lee
Jee-Eun Lee
YOYoon-Sang Oh
Yoon-Sang Oh
SYSang-Won Yoo
Sang-Won Yoo
KLKwang-Soo Lee
Kwang-Soo Lee
Previous single-center or meta-analysis studies analyzed myocardial 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in a single image session and demonstrated low sensitivity and high specificity for discriminating Parkinson disease (PD) from atypical Parkinsonian syndromes (APS). This study aimed to assess diagnostic ability of myocardial 123I-MIBG scintigraphy at 2 phases to discriminate PD from APS. This hospital-based prospective study enrolled 162 PD and 26 APS patients who underwent 2 sequential 123I-MIBG scintigraphy evaluations. Patients were stratified into normal and decreased 123I-MIBG groups according to early and delayed heart-to-mediastinum (H/M) ratios. Patients with PD and normal 123I-MIBG uptake (initial delayed H/M ratio, ≥1.78) were considered scans without evidence of cardiac norepinephrine deficit (SWEND). Early and delayed H/M ratios on the initial and 2-year follow-up scintigraphs were studied. The diagnostic sensitivity and specificity were calculated from these confusion matrices and were analyzed according to receiver-operating characteristic curve analysis. A repeated-measures general linear model was used to investigate differences among groups over time in H/M ratio changes and washout rates. Follow-up 123I-MIBG scintigraphy analysis had a higher diagnostic sensitivity (89.5%) than the initial imaging (72.2%). The improved sensitivity was associated with a steeper decrease in H/M ratio in the SWEND group than in the APS group. Follow-up 123I-MIBG scintigraphy can identify cardiac sympathetic denervation and its progression in patients with PD and may be effective in discriminating PD from APS. A later decrease in myocardial 123I-MIBG uptake in the group with SWEND meets the Braak staging threshold hypothesis for synucleinopathy.

10 August 2021 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
NSNa-Young Shin
Na-Young Shin
YPYae Won Park
Yae Won Park
SYSang-Won Yoo
Sang-Won Yoo
JYJi-Yeon Yoo
Ji-Yeon Yoo
YCYangsean Choi
Yangsean Choi
JKJoong-Seok Kim
Joong-Seok Kim
Dilated perivascular space (dPVS) has recently been reported as a biomarker for cognitive impairment in Parkinson’s disease (PD). However, comprehensive interrelationships between various clinical risk factors, dPVS, white-matter hyperintensities (WMH), cognition, and motor function in PD have not been studied yet. The purpose of this study was to test whether dPVS might mediate the effect of clinical risk factors on WMH, cognition, and motor symptoms in PD patients. A total of 154 PD patients were assessed for vascular risk factors (hypertension, diabetes mellitus, and dyslipidemia), autonomic dysfunction (orthostatic hypotension and supine hypertension [SH]), APOE ε4 genotype, rapid eye movement sleep-behavior disorder, motor symptoms, and cognition status. The degree of dPVS was evaluated in the basal ganglia (BG) and white matter using a 5-point visual scale. Periventricular, deep, and total WMH severity was also assessed. Path analysis was performed to evaluate the associations of these clinical factors and imaging markers with cognitive status and motor symptoms. Hypertension and SH were significantly associated with more severe BGdPVS, which was further associated with higher total WMH, consequently leading to lower cognitive status. More severe BGdPVS was also associated with worse motor symptoms, but without mediation of total WMH. Similar associations were seen when using periventricular WMH as a variable, but not when using deep WMH as a variable. In conclusion, BGdPVS mediates the effect of hypertension and SH on cognitive impairment via total and periventricular WMH, while being directly associated with more severe motor symptoms.

14 April 2021 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
SYSang-Won Yoo
Sang-Won Yoo
JKJoong-Seok Kim
Joong-Seok Kim
JYJi-Yeon Yoo
Ji-Yeon Yoo
EYEunkyeong Yun
Eunkyeong Yun
UYUicheul Yoon
Uicheul Yoon
KLKwang-Soo Lee
Kwang-Soo Lee
Orthostatic hypotension (OH) is relatively common in the early stage of Parkinson’s disease (PD). It is divided into delayed OH and classical OH. Classical OH in PD has been investigated widely, however, the clinical implications of delayed OH in PD have seldom been studied. The purpose of this study is to characterize delayed OH in PD. A total of 285 patients with early drug-naïve PD were enrolled and divided into three groups according to orthostatic change: no-OH, delayed OH, and classical OH. The disease severity in terms of motor, non-motor, and cognitive functions was assessed. The cortical thickness of 82 patients was analyzed with brain magnetic resonance imaging. The differences among groups and linear tendency in the order of no-OH, delayed OH, and classical OH were investigated. Seventy-seven patients were re-evaluated. Initial and follow-up evaluations were explored to discern any temporal effects of orthostasis on disease severity. Sixty-four (22.5%) patients were defined as having delayed OH and 117 (41.1%) had classical OH. Between-group comparisons revealed that classical OH had the worst outcomes in motor, non-motor, cognitive, and cortical thickness, compared to the other groups. No-OH and delayed OH did not differ significantly. Linear trends across the pre-ordered OH subtypes found that clinical parameters worsened along with the orthostatic challenge. Clinical scales deteriorated and the linear gradient was maintained during the follow-up period. This study suggests that delayed OH is a mild form of classical OH in PD. PD with delayed OH has milder disease severity and progression.

25 August 2019 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
YOYoon‐Sang Oh
Yoon‐Sang Oh
JKJoong-Seok Kim
Joong-Seok Kim
SYSang-Won Yoo
Sang-Won Yoo
EHE. ‐J. Hwang
E. ‐J. Hwang
CLChul Hyoung Lyoo
Chul Hyoung Lyoo
KLKwang‐Soo Lee
Kwang‐Soo Lee